Diabetes Congress 2025 | Dubai | UAE | Allied Conferences | Meetings

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academies Conferences

Theme

Revolutionizing Diabetes Care through Innovation and Collaboration

- Diabetes Congress 2025

Welcome Message

We are delighted to welcome all esteemed participants, honored speakers, researchers, and professionals to Diabetes Congress 2025, the 12th International Conference on Diabetes and Metabolic Disorders, taking place on March 5-6, 2025, in the dynamic city of Dubai, UAE.

This milestone event promises to be a pivotal platform for sharing groundbreaking research in diabetes, endocrinology, metabolism, and related disciplines. With a focus on addressing pressing challenges such as the global rise in diabetes prevalence, advancements in insulin therapies, continuous glucose monitoring, artificial pancreas systems, and the role of precision medicine in diabetes care, the conference fosters collaboration among global experts dedicated to improving patient outcomes.

Set in Dubai, a city renowned for its modern innovations, cultural diversity, and world-class facilities, the event offers the perfect environment for inspiring discussions and knowledge exchange. Dubai’s commitment to fostering scientific advancements and its position as a global hub makes it an ideal destination for this enriching gathering.

During Diabetes Congress 2025, we encourage you to actively engage in thought-provoking sessions, connect with fellow professionals, and explore the vast opportunities to advance diabetes research and treatment strategies. Together, let’s address the growing burden of diabetes and work towards innovative, sustainable solutions to enhance global health outcomes.

Once again, welcome to Diabetes Congress 2025. We wish you a highly rewarding and memorable experience in Dubai, UAE!

Warm regards,
Mark Antony
Program Manager | Diabetes Congress 2025

About

The 33rd International Conference on Diabetes and Endocrinology is a prestigious global gathering that unites innovators, researchers, scientists, healthcare professionals, organizations, and industry leaders to advance the fields of diabetes and endocrinology. The conference, themed “Revolutionizing Diabetes Care through Innovation and Collaboration,” aims to explore groundbreaking research, cutting-edge developments, and transformative solutions in these rapidly evolving disciplines.

This event provides a comprehensive platform to discuss advancements in diabetes prevention, diagnosis, treatment, and management. It will also address emerging research on continuous glucose monitoring (CGM), artificial pancreas systems, advancements in insulin therapies, and the integration of digital health technologies for personalized diabetes care.

Key Benefits of the Conference

Gain insights into the latest advancements and innovations in diabetes and endocrinology.
Engage with eminent speakers presenting their cutting-edge frameworks, findings, and applications in these fields.
Stay updated on the current trends and breakthroughs, including the impact of precision medicine, novel therapeutics, and AI-driven solutions for diabetes management.
Explore a diverse range of topics, such as obesity management, diabetic neuropathy, cardiovascular risks, gestational diabetes, and lifestyle interventions.
Participate in poster presentations and the Young Researcher Forum, providing students and early-career researchers a platform to showcase their work and compete for the Best Poster Award.

The 33rd International Conference on Diabetes and Endocrinology is an unmissable opportunity to network, collaborate, and stay at the forefront of transformative research and clinical advancements. Join us in Dubai, UAE, on March 5-6, 2025, to shape the future of diabetes care and endocrinology!

Past Conference

2021: Frankfurt, Germany

Dates: November 29-30, 2021

Key Topics:

Precision medicine in diabetes care
Advances in telehealth and glucose monitoring
Participation:
250+ attendees from 30+ countries
Notable Sessions:
Keynote on managing Type 1 and Type 2 diabetes
Hands-on workshops with new monitoring technologies

2022: Prague, Czech Republic

Dates: July 15-16, 2022

Key Topics:

Emerging therapies in diabetes and endocrine oncology
Innovations in pediatric endocrinology
Participation:
300+ participants, significant European representation
Notable Sessions:
Panel discussion on endocrine disruptors and public health
Case studies on diabetes reversal

2023: Rome, Italy

Dates: December 14-16, 2023

Key Topics:

Advancements in insulin delivery systems
Role of digital health in endocrinology
Participation:
400+ delegates, strong industry and academic collaboration
Notable Sessions:
Clinical trials for metabolic disorder treatments
AI-driven diagnostics in endocrinology

2024: London, UK

Dates: July 14-15, 2024

Key Topics:

Innovations in obesity management
Diabetes prevention strategies
Endocrine genetics and personalized care
Participation:
350+ attendees with global reach
Notable Sessions:
Roundtable on endocrine research trends
Interactive workshops on diabetes prevention

Sessions

Session: 1

Artificial Intelligence in Diabetes Management: Artificial Intelligence (AI) is transforming diabetes management by enabling early diagnosis, personalized treatment, and precise glucose monitoring. AI-powered tools, such as continuous glucose monitors and insulin delivery systems, provide real-time insights and optimize care. Additionally, AI enhances patient education and supports physicians with data-driven clinical decisions. These advancements aim to improve outcomes and simplify disease management.

1.1 Machine learning for glucose prediction

1.2 AI-powered insulin delivery systems

1.3 AI-based diabetic retinopathy screening

1.4 Predictive models for diabetic complications

1.5 AI in diabetes patient education

Related Conferences:

Global Diabetes Summit 2025| International Symposium on Diabetes and Metabolic Disorders| European Diabetes Congress 2025| International Conference on Endocrinology and Diabetes Research| World Diabetes & Endocrinology Congress 2025| Australasian Diabetes Congress 2025| Diabetes and Endocrinology Conference| International Conference on Diabetes and Endocrinology

Related Associations:

American Diabetes Association (ADA), European Association for the Study of Diabetes (EASD),International Diabetes Federation(IDF),International Society of Endocrinology (ISE),Australian Diabetes Society (ADS), Latin American Diabetes Association (ALAD), Society for Endocrinology, Diabetes UK, International Society for Pediatric and Adolescent Diabetes (ISPAD), American Association of Clinical Endocrinologists (AACE)

Session: 2

Continuous Glucose Monitoring (CGM): Continuous Glucose Monitoring (CGM) is a technology that tracks blood glucose levels in real-time using a small sensor placed under the skin. It provides continuous data, enabling users to detect trends and fluctuations in glucose levels throughout the day and night. This helps in proactive diabetes management, reduces hypoglycemic events, and supports personalized treatment decisions.

2.1 Long-term outcomes of CGM in diabetes care

2.2 Non-invasive glucose monitoring technologies

2.3 Real-time glucose monitoring during exercise

2.4 CGM for gestational diabetes management

2.5 Integration of CGM with insulin pumps

Related Conferences:

Related Associations:

Session: 3

Precision Medicine in Diabetes: Precision Medicine in Diabetes focuses on tailoring prevention, diagnosis, and treatment strategies based on an individual’s genetic, environmental, and lifestyle factors. By analyzing unique patient data, it enables targeted therapies, such as personalized medications and diet plans, improving outcomes and reducing the risk of complications. This approach shifts from a one-size-fits-all model to customized care for optimal diabetes management.

3.1 Genetic markers for personalized diabetes care

3.2 Pharmacogenomics in diabetes treatment

3.3 Tailored nutrition plans for glycemic control

3.4 Individualized exercise regimens for diabetes

3.5 Role of epigenetics in diabetes progression

Related Conferences:

Related Associations:

Session: 4

Advances in Beta-Cell Therapy: Advances in beta-cell therapy have brought new hope for managing diabetes by targeting the restoration of insulin production. Recent innovations include stem cell-derived beta cells and gene editing technologies like CRISPR, enabling precise modification of insulin-producing cells. Encapsulation techniques protect transplanted cells from immune attack, enhancing longevity and efficacy. These breakthroughs are paving the way toward a functional cure for diabetes.

4.1 Stem-cell-derived beta-cell therapy

4.2 Encapsulation techniques for beta-cell protection

4.3 Immune modulation for beta-cell survival

4.4 Advances in islet transplantation

4.5 Novel beta-cell imaging techniques

Related Conferences:

Related Associations:

Session: 5

Gut Microbiome and Diabetes: The gut microbiome plays a crucial role in diabetes, influencing glucose metabolism, insulin sensitivity, and inflammation. Dysbiosis, or an imbalance in gut microbes, has been linked to the development of type 2 diabetes and obesity. Research suggests that modulating the gut microbiota through diet, probiotics, or prebiotics could improve metabolic health and offer new therapeutic avenues for diabetes management.

5.1 Gut bacteria influencing insulin resistance

5.2 Microbiome-targeted therapies for Type 2 diabetes

5.3 Role of short-chain fatty acids in glycemic control

5.4 Microbiota interventions in prediabetes

5.5 Antibiotics and their impact on gut health in diabetes

Related Conferences:

Related Associations:

Session: 6

Emerging Drug Therapies: Emerging drug therapies for diabetes focus on innovative approaches such as dual or triple agonists targeting GLP-1, GIP, and glucagon receptors, offering enhanced glucose control and weight management. Novel oral insulin formulations aim to simplify administration and improve patient adherence. Advanced therapies like stem cell-derived beta-cell transplants and gene editing hold promise for potentially reversing diabetes by addressing its root causes.

6.1 SGLT2 inhibitors for cardiovascular risk reduction

6.2 GLP-1 receptor agonists and weight management

6.3 Dual agonists for glucose and weight control

6.4 Novel oral insulin formulations

6.5 Small-molecule therapies targeting insulin pathways

Related Conferences:

Related Associations:

Session: 7

Diabetes and COVID-19: Diabetes significantly increases the risk of severe illness from COVID-19 due to weakened immune response and higher susceptibility to complications like pneumonia and organ damage. Poorly managed blood sugar levels can exacerbate inflammation, making recovery more challenging. Ensuring optimal diabetes management and vaccination is crucial to reduce risks.

7.1 Impact of COVID-19 on glycemic control

7.2 Diabetes as a risk factor for severe COVID-19

7.3 Management of diabetes in post-COVID syndromes

7.4 Long-term metabolic effects of COVID-19 in diabetics

7.5 Vaccination responses in diabetic patients

Related Conferences:

Related Associations:

Session: 8

Pediatric Diabetes Advances: Advances in pediatric diabetes management focus on improving early diagnosis, glucose monitoring, and personalized treatment. Continuous glucose monitors (CGMs) and automated insulin delivery systems, often called "artificial pancreas" systems, provide real-time data and optimize insulin dosing. AI-powered apps and wearable devices enhance self-management and adherence in children, while genetic research is paving the way for novel therapeutic approaches.

8.1 New insights into monogenic diabetes in children

8.2 Early diagnosis of Type 1 diabetes in high-risk children

8.3 Innovations in insulin dosing for pediatric patients

8.4 Impact of diet trends on childhood diabetes

8.5 School-based diabetes management programs

Related Conferences:

Related Associations:

Session: 9

Cardiometabolic Health in Diabetes: Cardiometabolic Health in Diabetes focuses on the intricate relationship between diabetes, cardiovascular disease, and metabolic disorders. Individuals with diabetes are at a higher risk for heart disease and stroke due to interconnected factors like insulin resistance, hypertension, and dyslipidemia. Addressing cardiometabolic health involves integrated strategies, including glycemic control, lifestyle modifications, and cardiovascular risk management, to improve overall outcomes.

9.1 Role of LDL-c and triglycerides in diabetes

9.2 Hypertension management in diabetic patients

9.3 Cardiovascular outcomes of GLP-1 agonists

9.4 Atherosclerosis prevention in Type 2 diabetes

9.5 Lipid-lowering therapies and diabetes

Related Conferences:

Related Associations:

Session: 10

Insulin Innovations: Insulin innovations are revolutionizing diabetes management by improving the precision and efficiency of insulin delivery. New insulin formulations, such as ultra-rapid and long-acting insulins, offer better control over blood sugar levels and more flexibility for patients. Additionally, smart insulin pens and pumps, integrated with continuous glucose monitoring (CGM) systems, enable real-time adjustments, optimizing insulin doses and enhancing overall treatment. These advancements aim to improve patient outcomes and make diabetes management more convenient and effective.

10.1 High-concentration insulin analogs

10.2 Ultra-rapid-acting insulins

10.3 Smart insulin pens with data tracking

10.4 Development of glucose-responsive insulins

10.5 Bioconjugated insulin therapies

Related Conferences:

Related Associations:

Session: 11

Diabetic Retinopathy: Diabetic retinopathy is a diabetes-related eye condition that occurs when high blood sugar levels damage the blood vessels in the retina. It is one of the leading causes of blindness in adults. Early stages often show no symptoms, but as the condition progresses, it can cause vision loss. Regular eye exams are crucial for early detection and management to prevent severe vision impairment.

11.1 AI-assisted retinopathy screening tools

11.2 Intravitreal injections for retinopathy management

11.3 Anti-VEGF therapies for diabetic eye disease

11.4 Retinal imaging advancements

11.5 Genetic predisposition studies

Related Conferences:

Related Associations:

Session: 12

Diabetic Neuropathy: Diabetic neuropathy is a type of nerve damage caused by prolonged high blood sugar levels in individuals with diabetes. It commonly affects the legs and feet, leading to symptoms like numbness, tingling, pain, and weakness. Over time, it can result in severe complications, including infections, ulcers, and amputations, if not properly managed. Early detection and blood sugar control are essential in preventing or slowing its progression.

12.1 Advances in pain management for neuropathy

12.2 Regenerative therapies for nerve damage

12.3 Non-invasive diagnostic tools

12.4 Role of glycemic variability in neuropathy progression

12.5 Biomarkers for early neuropathy detection

Related Conferences:

Related Associations:

Session: 13

Diabetes in Women’s Health: Diabetes in women presents unique challenges, as hormonal fluctuations, especially during pregnancy, menstruation, and menopause, can influence blood sugar levels. Women with diabetes are at a higher risk of developing complications such as heart disease, kidney issues, and gestational diabetes. Additionally, social and cultural factors may affect access to care, making it crucial to address diabetes management with a gender-sensitive approach. Empowering women with diabetes through education, early detection, and personalized care is key to improving their long-term health outcomes.

13.1 Polycystic ovary syndrome (PCOS) and diabetes

13.2 Maternal-fetal outcomes in gestational diabetes

13.3 Hormonal therapies and diabetes risk

13.4 Diabetes and menopause: A metabolic challenge

13.5 Fertility treatments in diabetic women

Related Conferences:

Related Associations:

Session: 14

Endocrine Disruptors and Diabetes: Endocrine disruptors are chemicals that interfere with the normal functioning of the endocrine system, which regulates hormone production and activity. Exposure to these disruptors, found in everyday products like plastics, pesticides, and personal care items, has been linked to an increased risk of developing diabetes. These chemicals can alter insulin sensitivity, promote fat accumulation, and interfere with glucose metabolism, contributing to the onset and progression of type 2 diabetes. Reducing exposure to endocrine disruptors is an emerging focus in preventing diabetes and other metabolic disorders.

14.1 Environmental toxins influencing insulin resistance

14.2 Endocrine disruptors and childhood obesity

14.3 Role of plastics in diabetes development

14.4 Pesticides and diabetes prevalence

14.5 Strategies to reduce exposure to endocrine disruptors

Related Conferences:

Related Associations:

Session: 15

Digital Health in Endocrinology: Digital health in endocrinology leverages technology to improve the diagnosis, monitoring, and treatment of endocrine disorders. Through tools like wearable devices, mobile apps, and telemedicine, patients with conditions such as diabetes, thyroid disorders, and obesity can receive personalized care and continuous monitoring. These innovations enable real-time data collection, remote consultations, and more efficient management, empowering patients and healthcare providers to make informed decisions. Digital health also supports the development of predictive models for better disease management and outcomes.

15.1 Wearable devices for endocrine health tracking

15.2 Endocrinology apps for patient engagement

15.3 Remote monitoring tools in diabetes

15.4 Blockchain for endocrinology data security

15.5 Virtual reality in diabetes education

Related Conferences:

Related Associations:

Session: 16

Advanced Imaging in Endocrinology: Advanced imaging in endocrinology enhances the diagnosis and management of endocrine disorders by providing detailed visualizations of glandular structures and tissue abnormalities. Techniques like MRI, CT scans, and high-resolution ultrasound help in assessing conditions such as thyroid nodules, pituitary tumors, and adrenal disorders. Functional imaging, such as PET and SPECT scans, further aids in detecting hormone-secreting tumors and guiding treatment decisions. These imaging modalities enable early detection, precise localization, and monitoring of endocrine diseases, improving patient outcomes.

16.1 Imaging techniques for pancreatic beta-cells

16.2 Advances in adrenal gland imaging

16.3 Thyroid nodules: AI in imaging diagnostics

16.4 MRI-based studies of pituitary function

16.5 Bone health assessments in diabetes

Related Conferences:

Related Associations:

Session: 17

Endocrine Cancers: Endocrine cancers are malignancies that originate in the hormone-producing glands of the endocrine system, including the thyroid, adrenal glands, and pancreas. These cancers can affect hormone production and lead to symptoms such as weight changes, fatigue, or abnormal growth patterns. Early detection and advancements in treatments like targeted therapy and immunotherapy have improved patient outcomes. Management typically involves surgery, radiation, and medication to control hormone levels and prevent recurrence.

17.1 Thyroid cancer: Emerging biomarkers

17.2 Advances in adrenal cancer treatments

17.3 Role of insulin in pancreatic cancer

17.4 Neuroendocrine tumors and diabetes links

17.5 Hormonal therapies for endocrine cancers

Related Conferences:

Related Associations:

Session: 18

Nutrition in Diabetes and Endocrinology: Nutrition plays a crucial role in the management of diabetes and endocrine disorders by influencing blood sugar levels, hormone regulation, and overall metabolic health. A well-balanced diet, tailored to individual needs, helps in managing insulin sensitivity, preventing complications, and improving long-term outcomes. In diabetes, controlling carbohydrate intake and focusing on nutrient-dense foods can stabilize blood glucose, while in endocrine conditions like hypothyroidism or polycystic ovary syndrome (PCOS), specific dietary adjustments can support hormone balance and weight management. Personalized nutrition strategies are vital for optimal disease management and quality of life.

18.1 Time-restricted eating in diabetes care

18.2 Role of plant-based diets in metabolic health

18.3 Impact of ketogenic diets on diabetes

18.4 Omega-3 fatty acids and glycemic control

18.5 Probiotics in diabetes management

Related Conferences:

Related Associations:

Session: 19

Exercise and Diabetes Management: Exercise plays a crucial role in managing diabetes by improving insulin sensitivity, regulating blood sugar levels, and promoting overall metabolic health. Regular physical activity helps prevent the onset of type 2 diabetes in at-risk individuals and supports better control of blood glucose in those already diagnosed. It also reduces the risk of complications related to diabetes, such as cardiovascular disease, and enhances overall quality of life. A combination of aerobic exercise, strength training, and flexibility exercises is often recommended for optimal diabetes management.

19.1 Resistance training for glycemic improvement

19.2 High-intensity interval training (HIIT) and insulin sensitivity

19.3 Wearables to optimize exercise for diabetes

19.4 Exercise prescriptions for gestational diabetes

19.5 Strategies to prevent hypoglycemia during exercise

Related Conferences:

Related Associations:

Session: 20

Geriatric Endocrinology: Geriatric endocrinology focuses on the unique endocrine needs of older adults, addressing age-related hormonal changes and their impact on health. Common concerns include osteoporosis, diabetes, thyroid disorders, and adrenal insufficiency, which often require specialized management in the elderly due to comorbidities and polypharmacy. Geriatric endocrinologists aim to optimize treatment strategies, improve quality of life, and prevent complications through a comprehensive, patient-centered approach tailored to aging physiology.

20.1 Diabetes care in older adults: Polypharmacy challenges

20.2 Endocrine changes in aging populations

20.3 Management of osteoporosis in diabetic elderly

20.4 Cognitive decline and diabetes link

20.5 Frailty and diabetes management in geriatrics

Related Conferences:

Related Associations: